Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies

Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies

10.1177/0269881113480990

Saved in:
Bibliographic Details
Main Authors: Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., Rabiner, E.A., Trist, D., Trower, M., Zamuner, S., Krishnan, R., Fava, M.
Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format: Article
Published: 2014
Subjects:
clinical trials
Depression
neurokinin
receptor occupancy
substance P
Online Access:http://scholarbank.nus.edu.sg/handle/10635/110538
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Similar Items

Similar Items